✦ LIBER ✦

PCN11 COST EFFECTIVENESS OF ADJUVANT, INTRAVESICAL THERAPY FOR NON-INVASIVE TRANSITIONAL CELL CARCINOMA OF THE BLADDER

✍ Scribed by M Kerrigan; SD Ramsey; D Penson; DK Blough; L Garrison

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravesical therapy for transitional ce

✍ Can Öbek; Scott W. Shelfo; Howard J. Korman; Mark S. Soloway 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Neo-adjuvant (Pre-emptive) Cisplatin The

✍ D. M. A. WALLACE; D. RAGHAVAN; K. A. KELLY; T. F. SANDEMAN; I. G. CONN; N. TERIA 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 654 KB

C34 THE ROLE OF ADJUVANT INTRAVESICAL BC

✍ Gluck, G.; Chirita, M.M.; Stoica, R.; Daia, D.; Sinescu, I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 279 KB

The natural history of non-muscle-invasi

✍ A.J. Colquhoun; R.C. Kockelbergh 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 119 KB

Selective bladder preservation for muscl

✍ Michaelson, M D; Shipley, W U; Heney, N M; Zietman, A L; Kaufman, D S 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 75 KB

Single Dose Intravesical Thiotepa as an

✍ K. G. BURNAND; P. J. R. BOYD; M. E. MAYO; K. E. D. SHUTTLEWORTH; R. W. LLOYD-DAV 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB